The management of ductal carcinoma in situ is one of the most controversial areas in breast cancer management.
Henry M. Kuerer, MD, PhD, FACS
Advertisement
Articles by Henry M. Kuerer, MD, PhD, FACS
Advertisement
Latest Updated Articles
Controversies and Clinical Trials for DCIS: Margins and Active SurveillancePublished: January 1st 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL
5